Description

Reliable intestinal organoid establishment begins with the recovery of intact, viable intestinal crypts. During conventional intestinal tissue digestion, insufficient dissociation can leave crypts trapped within the mucosa, while excessive enzymatic or mechanical treatment may disrupt crypt architecture and reduce the ability of intestinal stem cell-containing units to initiate new organoids.

Biofargo Organoid Intestinal Digestion Solution is an optimized intestinal tissue digestion solution developed for controlled dissociation of adult or mouse intestinal tissue. The formulation is designed to release structurally intact crypt units from intestinal mucosal tissue while minimizing unnecessary digestion-related stress and damage.

This ready-to-use intestinal crypt isolation solution supports the preparation of small intestinal and colonic crypts for downstream intestinal organoid culture. Under the documented workflow, tissue is digested at 4°C and requires only gentle pipetting after digestion, helping researchers recover crypts suitable for embedding in an appropriate extracellular matrix and culture in a compatible intestinal organoid medium.

Specifications

Product Name	Biofargo Organoid Intestinal Digestion Solution
SKU	BiofargoIOTDIGST-100
Product Type	Intestinal tissue digestion and crypt isolation solution
Primary Sample Types	Adult or mouse intestinal tissue
Target Structures	Small intestinal crypts and colonic crypts
Size	100 mL
Endotoxin	≤0.1 EU/mL
Filtration	<0.2 μm
Bacteria Detection	Not detected
Fungi Detection	Not detected
Storage	15–25°C
Shelf Life	12 months
Grade	For research use only

Features

Optimized specifically for intestinal tissue digestion and intestinal crypt isolation
Designed for adult or mouse intestinal tissue sample preparation
Supports recovery of intact small intestinal and colonic crypt units
Uses controlled low-temperature digestion to help reduce excessive tissue damage
Requires only gentle pipetting after the documented digestion step
Helps preserve crypt structure for downstream intestinal organoid establishment
Suitable for organoid culture workflows involving crypt extraction, matrix embedding and expansion
Low-endotoxin formulation filtered through a <0.2 μm process
Convenient room-temperature storage at 15–25°C

How It Works

Intestinal crypt isolation requires separation of epithelial crypt structures from surrounding mucosal tissue without unnecessarily breaking the recovered units into dispersed single cells. Biofargo Organoid Intestinal Digestion Solution is formulated to support this balance through a controlled intestinal tissue dissociation workflow.

After the intestinal sample has been cleaned and cut into small fragments, the tissue is incubated with the digestion solution at 4°C. Gentle pipetting following digestion helps release crypt structures. The suspension is then filtered and centrifuged to collect the recovered crypt-containing fraction for downstream organoid culture.

Important: The documented 25–30 minute digestion period is a reference condition. Intestinal region, tissue thickness, sample source and fragment size may affect dissociation efficiency. Monitor crypt release and avoid excessive mechanical pipetting or prolonged digestion.

Recommended Workflow

Clean the intestinal tissue and cut it into approximately 1 mm × 1 mm fragments.
Add 10 mL of precooled PBS and agitate the tube to wash the intestinal fragments and remove intestinal contents.
Repeat the PBS washing process three times.
Add 10 mL of Biofargo Organoid Intestinal Digestion Solution.
Digest the tissue on a shaker at 4°C for approximately 25 minutes.
Remove the digestion solution after incubation.
Add 5 mL of an appropriate termination solution to stop digestion.
Gently pipette the digested intestinal fragments using a 5 mL pipette.
Filter the tissue suspension through a 70 μm cell strainer.
Centrifuge at 300 × g for 5 minutes and remove the supernatant.
Process the recovered crypt fraction using the appropriate matrix and intestinal organoid culture medium for the intended workflow.

Workflow note: The termination solution, extracellular matrix and intestinal organoid culture medium are separate workflow components unless specifically stated in the ordering information.

Performance Data

Small Intestinal and Colonic Crypt Recovery

Under the documented test conditions, intestinal tissue was digested at 4°C for approximately 25–30 minutes. Following gentle pipetting with a 5 mL pipette, crypt structures could be recovered from both small intestinal and colonic tissue samples.

Small intestinal crypt and colon crypt isolation results after intestinal tissue digestion

Representative small intestinal crypt and colonic crypt recovery following controlled intestinal tissue digestion.

The recovered crypts showed preserved structural integrity under the evaluated conditions. The product documentation indicates that the isolated crypts can be combined with a corresponding organoid culture medium and matrix to support subsequent intestinal organoid formation.

Applications

Biofargo Organoid Intestinal Digestion Solution is designed for intestinal tissue processing workflows in which the recovery of structurally intact crypt units is required before three-dimensional culture. It can be incorporated into organoid research workflows involving small intestinal or colonic tissue samples.

Intestinal crypt isolation: Controlled release and collection of crypt structures from intestinal mucosal tissue.
Small intestinal crypt isolation: Preparation of small intestinal crypts for matrix embedding and organoid initiation.
Colon crypt isolation: Recovery of colonic crypt structures for colon organoid culture workflows.
Mouse intestinal organoid culture: Preparation of mouse intestinal tissue before crypt-based organoid establishment.
Adult intestinal tissue processing: Dissociation of adult intestinal samples for downstream organoid research.
Intestinal organoid establishment: Sample preparation before crypt embedding in an appropriate extracellular matrix.
Intestinal organoid expansion: Preparation of newly isolated crypt units for subsequent growth in a compatible culture system.
Intestinal stem cell research: Recovery of crypt units containing the epithelial stem cell compartment for research applications.
Three-dimensional intestinal culture: Tissue preparation for 3D intestinal epithelial and organoid models.
Gastrointestinal disease modeling: Establishment of intestinal organoid cultures for research into epithelial biology and disease mechanisms.
Drug response research: Generation of intestinal organoid models for laboratory evaluation of experimental treatment responses.
Regenerative biology research: Study of intestinal epithelial renewal, differentiation and tissue organization using organoid platforms.

Why Use an Intestinal-Specific Digestion Solution?

General-purpose tissue dissociation reagents may not provide the level of control required for intestinal crypt extraction. A digestion condition that is too weak may produce low crypt recovery, while overly aggressive treatment may fragment crypts, increase cellular stress and compromise downstream organoid formation.

Biofargo Organoid Intestinal Digestion Solution is optimized around the specific requirement to separate crypt structures from intestinal mucosa while maintaining their overall architecture. Its low-temperature workflow and limited mechanical handling help researchers standardize a critical early step in intestinal organoid culture.

By combining targeted intestinal tissue dissociation with gentle crypt recovery, the solution is suitable for laboratories seeking a more controlled approach to small intestinal and colon organoid sample preparation.

Factors That Can Affect Crypt Isolation

Tissue fragment size: Uneven or oversized fragments may digest inconsistently.
Intestinal region: Small intestinal and colonic tissues may differ in dissociation behavior.
Sample condition: Collection method, storage time and tissue condition may influence crypt recovery.
Digestion duration: Insufficient incubation may reduce release, while excessive digestion may damage crypt structures.
Mechanical force: Vigorous or repeated pipetting may disrupt intact crypts.
Temperature control: The documented workflow uses digestion at 4°C and should not be assumed to perform identically at other temperatures.
Downstream culture system: Organoid formation also depends on matrix selection, culture medium, seeding density and sample quality.

FAQ

What is Biofargo Organoid Intestinal Digestion Solution used for?

Biofargo Organoid Intestinal Digestion Solution is used for controlled intestinal tissue digestion and the isolation of crypt structures from adult or mouse intestinal tissue before intestinal organoid culture.

Is this product an intestinal crypt isolation reagent?

Yes. It is specifically optimized as an intestinal crypt isolation solution that helps release intact crypt units from intestinal mucosal tissue under the documented low-temperature digestion workflow.

Can this solution be used for small intestinal crypt isolation?

Yes. The product documentation includes recovery results for small intestinal crypts following digestion at 4°C and gentle pipetting.

Can it be used for colon crypt isolation?

Yes. The documented applications and performance images include the isolation of colonic crypts from intestinal tissue.

Is the product suitable for mouse intestinal organoid culture?

Yes. The product is described for adult or mouse intestinal tissue samples and can be used during the crypt isolation stage of a mouse intestinal organoid culture workflow.

Can it be used with adult intestinal tissue?

Yes. The product documentation describes its use with adult intestinal tissue. Digestion conditions should still be monitored and optimized according to tissue source, intestinal region and sample condition.

Does the solution dissociate intestinal tissue into single cells?

The documented workflow is intended primarily to release intact crypt units rather than completely dissociate the sample into a single-cell suspension. The final outcome may vary with digestion time and mechanical handling.

Why is intestinal crypt integrity important for organoid culture?

Intact crypt units contain the epithelial compartment required to initiate intestinal organoid growth. Excessive digestion or vigorous pipetting may disrupt crypt architecture and reduce the quality of the recovered starting material.

What digestion temperature is recommended?

The documented workflow uses digestion at 4°C on a shaker. The product should not be assumed to provide the same results at other temperatures without additional optimization.

How long should intestinal tissue be digested?

The documented workflow uses approximately 25 minutes, while the performance notes describe a 25–30 minute range. The actual endpoint should be determined by monitoring crypt release and the condition of the tissue.

How much digestion solution is used in the documented workflow?

The provided procedure uses 10 mL of intestinal digestion solution for the prepared intestinal tissue fragments. Appropriate volume may depend on tissue quantity and vessel size.

Is mechanical dissociation required after digestion?

Yes. The documented workflow uses gentle pipetting with a 5 mL pipette after digestion. Excessive pipetting should be avoided because it may damage crypt structures.

What cell strainer is used after intestinal tissue digestion?

The documented protocol uses a 70 μm cell strainer to filter the digested tissue suspension before centrifugation.

What centrifugation condition is recommended for crypt collection?

The provided workflow specifies centrifugation at 300 × g for 5 minutes, followed by removal of the supernatant.

Does this product include an organoid culture medium or matrix?

The product is an intestinal tissue digestion solution. A compatible intestinal organoid culture medium, extracellular matrix and any required termination solution should be selected separately unless they are specifically included in the ordered configuration.

How should Biofargo Organoid Intestinal Digestion Solution be stored?

The product should be stored at 15–25°C. The stated shelf life is 12 months under the specified storage conditions.

Is the product sterile filtered?

The product specification states that it is filtered through a process with a pore size below 0.2 μm. Bacteria and fungi were not detected in the documented quality testing.

What is the endotoxin specification?

The stated endotoxin specification is ≤0.1 EU/mL.

Is this intestinal tissue digestion solution intended for clinical use?

No. Biofargo Organoid Intestinal Digestion Solution is intended for research use only and is not intended for diagnostic, therapeutic or clinical applications.

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

Intestinal Organoid Digestion Solution